This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
04/29/16 - 3:59:46 PM ET (BATS BZX Real-time Price)
Div Yield: --
FPRX Day's Range
FPRX 52 Week Range
FPRX Business Summary
Five Prime Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of protein therapeutics that block cancer and inflammatory disease processes in the United States.View FPRX
Five Prime Therapeutics Inc - FPRX - EQUITY
Reviewed By: TheStreet Ratings on .
Report Summary: TheStreet Ratings team rates Five Prime Therapeutics Inc as a
Hold with a ratings score of C+.
Report Snippet: We rate FIVE PRIME THERAPEUTICS INC (FPRX) a HOLD. The primary factors that have impacted our rating are mixed – some indicating strength, some showing weaknesses, with little evidence to justify the expectation of either a positive or negative performance for this stock relative to most other stocks. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures and notable return on equity. However, as a counter to these strengths, we find that the growth in the company's earnings per share has not been good.